Abstract The t (7; 12)(q36; p13)(MNX1/ETV6) is not included in the WHO classification but
has been described in up to 30% of acute myeloid leukemia (AML) in children< 2 years and …

Trisomy 8 (+ 8) is a common cytogenetic aberration in acute myeloid leukemia (AML);
however, the impact of+ 8 in pediatric AML is largely unknown. We retrospectively …

In pediatric acute myeloid leukemia (AML), cytogenetic abnormalities are strong indicators of
prognosis. Some recurrent cytogenetic abnormalities, such as t (8; 16)(p11; p13), are so rare …

The presence of chromosomal abnormalities is one of the most important criteria for
leukaemia diagnosis and management. Infant leukaemia is a rare disease that affects …

We report the nonrandom occurrence and frequency of the t (1; 22)(p13; q13) in acute
myeloid leukemia (AML) and its close association with the French-American-British M7 …

Abstract Monosomy 7 (− 7) and deletion 7q\del (7q) are rare in childhood acute myeloid
leukemia (AML). We retrospectively collected data on 258 children with AML or refractory …

Abstract The t (7; 21)(p22; q22) resulting in RUNX1‐USP42 fusion, is a rare but recurrent
cytogenetic abnormality associated with acute myeloid leukemia (AML) and myelodysplastic …

Following reports of childhood acute myeloid leukemia (AML) showing that patients with t (9;
11)(p22; q23) have a better prognosis than those with translocations between 11q23 and …

Acute myeloid leukemia with t (6; 9)(p22; q34) is listed as a distinct entity in the 2008 World
Health Organization classification, but little is known about the clinical implications of t (6; 9) …

Introduction Translocations involving the KMT2A gene (also known as MLL) are frequently
diagnosed in pediatric acute leukemia cases with either lymphoblastic or myeloid origin …